VEGFA and metastatic malignant neoplasm: Bevacizumab was discontinued resulting in the improvement of renal function and albuminuria.<h4>Discussion</h4>Bevacizumab, a humanized monoclonal antibody to VEGF is an approved therapy for metastatic cancer.